Stephen Opat

Adjunct Prof

1995 …2024
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Stephen Opat is the director of Clinical Haematology at Monash Health, a dynamic academic research organization that integrates the best evidence–base into routine patient care. It provides haematology care to a population of approximately 1.3 million, making it one of the largest services in Australia.  Key leadership areas in clinical care and research include: Lymphoid cancer, chronic myeloid disorders, thromboembolic disease, haemoglobinopathy and transfusion medicine. It is an active member of a number of research organisations including the Monash Health Translation Precinct (MHTP), the Centre for Cancer Research (CCR) at the Hudson Institute of Medical Research, and the Australasian Leukaemia and Lymphoma Group. His particular interests include the diagnosis and management of lymphoma and chronic lymphocytic leukaemia, cancer genomics, disorders of iron metabolism, Gaucher disease and novel therapies. He is the principal investigator in over 30 clinical trials mainly in lymphoid cancer and founder of the Australasian Lymphoma and Related Diseases Registry. He has a strong interest in medical education, particularly in developing countries, and has lectured widely throughout the Asia-Pacific. He is extremely active in the Haematology Society of Australia and New Zealand where he currently serves as President.

Keywords

  • Lymphoma
  • Genomics
  • Chronic Lymphocytic Leukaemia
  • Cancer Immunology
  • Cancer Cell Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2024

Research Output 1995 2019

Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS

Gregory, G., Dickinson, M. J., Yannakou, C., Wong, J., Blombery, P. A., Corboy, G., Kats, L., Crozier, T., Kumar, B., Miles Prince, H., Opat, S. S. & Shortt, J., Apr 2019, In : HemaSphere. 3, 2, 4 p., e187.

Research output: Contribution to journalLetterOtherpeer-review

Adaptive reprogramming of NK cells in X-Linked lymphoproliferative syndrome

Opat, S., Hearps, A. C., Thia, K., Yuen, A., Rogers, B., Chachage, M., Moore, G., Shortt, J., Ryland, G., Blombery, P., Schwarer, A. P., Noori, T., Trapani, J. A., Jaworowski, A. & Voskoboinik, I., 8 Feb 2018, In : Blood. 131, 6, p. 699-702 4 p.

Research output: Contribution to journalLetterOtherpeer-review

Concurrent Mycobacterium tuberculosis infection and nodal marginal zone lymphoma

Tedjaseputra, A., Kumar, B., de Silva, S. & Opat, S., 1 Jun 2018, In : Pathology. 50, 4, p. 464-466 3 p.

Research output: Contribution to journalLetterOtherpeer-review

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma

Cheah, C. Y., Joske, D., Cull, G., Gilbertson, M., Opat, S. S., Tam, C. S., Wirth, A. & Seymour, J. F., Sep 2017, In : British Journal of Haematology. 178, 6, p. 991-994 3 p.

Research output: Contribution to journalArticleResearchpeer-review